ComPro Pharma

Active

Private limited companyfounded 20206 yrs activeRue d'Ogné 36, 4140 Sprimont, BelgiumKBO/BCE: BE 0746.429.351

Summary

ComPro Pharma has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9,170 and a net result of €54,298. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 21% of 608 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisWatch Report Compare

ComPro PharmaActiveChecked score 88/100

Risk analysis Report Compare

History

ComPro Pharma was incorporated on 21 April 2020 as a Private limited company.¹ Revenue grew from €96,000 in 2020 to €160,650 in 2023.²

Acts, filings and financial milestones

All 8Financial 2Filings 6

Next filing, fiscal year 2026, expected by 31-07-2027

2026

28-05

NBB filing Annual accounts filed

fiscal year 2025 · micro schema

2025

20-06

NBB filing Annual accounts filed

fiscal year 2024 · micro schema

2024

31-12

Financial Highest result since 2020net €56,892 ▲1.6%

Operating result €71,913, net result €56,892, both a record.

26-07

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

2023

12-06

NBB filing Annual accounts filed

fiscal year 2022 · micro schema

2022

31-12

Financial Equity above €100,000Eq €130,971 ▲50.6%

3 profitable years in a row build equity to €130,971.

28-07

NBB filing Annual accounts filed

fiscal year 2021 · micro schema

2021

31-07

NBB filing Annual accounts filed

fiscal year 2020 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

0 of 1 act read

About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.